Farther Finance Advisors’s Avita Medical RCEL Stock Holding History

Farther Finance Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-62	Closed	-$260	–	6300
2026 Q2	$260	Buy	62 +52	+520%	+$224	﹤0.01%	5673
2026 Q1	$38	Buy	+10	New	+$42	﹤0.01%	5600
2025 Q4	–	Sell	-6,291	Closed	-$32.1K	–	5568
2025 Q3	$32.1K	Buy	+6,291	New	+$32.8K	﹤0.01%	2726

Other funds holding RCEL

HCA

Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors's RCEL Position: Q3 2026 in Review

Farther Finance Advisors sold out of Avita Medical (RCEL) in Q3 2026, closing a stake of 62 shares — an estimated $260 sold.

Farther Finance Advisors first reported a position in RCEL in Q3 2025 and held it in 3 quarters. The position peaked at $32.1K in Q3 2025. 4 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

Farther Finance Advisors reported no remaining Avita Medical position as of Q3 2026 after selling out during the quarter.
Farther Finance Advisors sold 62 Avita Medical shares in Q3 2026, an estimated $260.
Farther Finance Advisors first reported a position in Avita Medical in Q3 2025 and held it in 3 quarters.
Farther Finance Advisors's Avita Medical position peaked at $32.1K in Q3 2025.
4 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.